Annual CFO
-$540.59 M
-$80.55 M-17.51%
December 31, 2023
Summary
- As of February 7, 2025, SAGE annual cash flow from operations is -$540.59 million, with the most recent change of -$80.55 million (-17.51%) on December 31, 2023.
- During the last 3 years, SAGE annual CFO has fallen by -$1.20 billion (-181.38%).
- SAGE annual CFO is now -181.38% below its all-time high of $664.28 million, reached on December 31, 2020.
Performance
SAGE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$82.36 M
-$1.93 M-2.40%
September 30, 2024
Summary
- As of February 7, 2025, SAGE quarterly cash flow from operations is -$82.36 million, with the most recent change of -$1.93 million (-2.40%) on September 30, 2024.
- Over the past year, SAGE quarterly CFO has dropped by -$1.93 million (-2.40%).
- SAGE quarterly CFO is now -108.15% below its all-time high of $1.01 billion, reached on December 31, 2020.
Performance
SAGE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$320.15 M
+$53.50 M+14.32%
September 30, 2024
Summary
- As of February 7, 2025, SAGE TTM cash flow from operations is -$320.15 million, with the most recent change of +$53.50 million (+14.32%) on September 30, 2024.
- Over the past year, SAGE TTM CFO has increased by +$53.50 million (+14.32%).
- SAGE TTM CFO is now -143.84% below its all-time high of $730.29 million, reached on September 30, 2021.
Performance
SAGE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SAGE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.5% | -2.4% | +14.3% |
| 3 y3 years | -181.4% | -19.7% | -143.8% |
| 5 y5 years | -107.4% | +36.0% | +39.5% |
SAGE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.9% | at low | -117.7% | +46.4% | at high | +41.6% |
| 5 y | 5-year | -181.4% | at low | -108.2% | +46.4% | -143.8% | +41.6% |
| alltime | all time | -181.4% | at low | -108.2% | +46.4% | -143.8% | +41.6% |
Sage Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$82.36 M(+2.4%) | -$320.15 M(-14.3%) |
| Jun 2024 | - | -$80.44 M(+112.6%) | -$373.65 M(-12.0%) |
| Mar 2024 | - | -$37.83 M(-68.3%) | -$424.74 M(-21.4%) |
| Dec 2023 | -$540.59 M(+17.5%) | -$119.52 M(-12.0%) | -$540.59 M(-1.4%) |
| Sep 2023 | - | -$135.87 M(+3.3%) | -$548.00 M(+3.2%) |
| Jun 2023 | - | -$131.52 M(-14.4%) | -$531.00 M(+5.0%) |
| Mar 2023 | - | -$153.68 M(+21.1%) | -$505.92 M(+10.0%) |
| Dec 2022 | -$460.04 M(+21.6%) | -$126.93 M(+6.8%) | -$460.04 M(+6.8%) |
| Sep 2022 | - | -$118.86 M(+11.7%) | -$430.61 M(+13.1%) |
| Jun 2022 | - | -$106.44 M(-1.3%) | -$380.57 M(+1.0%) |
| Mar 2022 | - | -$107.80 M(+10.6%) | -$376.90 M(-0.3%) |
| Dec 2021 | -$378.18 M(-156.9%) | -$97.50 M(+41.7%) | -$378.18 M(-151.8%) |
| Sep 2021 | - | -$68.83 M(-33.0%) | $730.29 M(+3.1%) |
| Jun 2021 | - | -$102.77 M(-5.8%) | $708.10 M(+2.3%) |
| Mar 2021 | - | -$109.09 M(-110.8%) | $691.88 M(+4.2%) |
| Dec 2020 | $664.28 M(-225.6%) | $1.01 B(-1210.8%) | $664.28 M(-243.3%) |
| Sep 2020 | - | -$91.02 M(-23.5%) | -$463.42 M(-7.5%) |
| Jun 2020 | - | -$118.98 M(-13.0%) | -$501.10 M(-2.8%) |
| Mar 2020 | - | -$136.69 M(+17.1%) | -$515.46 M(-2.5%) |
| Dec 2019 | -$528.71 M(+102.8%) | -$116.73 M(-9.3%) | -$528.71 M(+2.9%) |
| Sep 2019 | - | -$128.70 M(-3.5%) | -$513.76 M(+10.4%) |
| Jun 2019 | - | -$133.34 M(-11.1%) | -$465.24 M(+40.1%) |
| Mar 2019 | - | -$149.93 M(+47.3%) | -$332.03 M(+27.4%) |
| Dec 2018 | -$260.67 M | -$101.78 M(+26.9%) | -$260.67 M(+19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$80.19 M(>+9900.0%) | -$217.79 M(+18.6%) |
| Jun 2018 | - | -$135.00 K(-99.8%) | -$183.70 M(-24.3%) |
| Mar 2018 | - | -$78.57 M(+33.4%) | -$242.64 M(+10.7%) |
| Dec 2017 | -$219.28 M(+84.8%) | -$58.90 M(+27.8%) | -$219.28 M(+12.9%) |
| Sep 2017 | - | -$46.09 M(-22.0%) | -$194.15 M(+8.6%) |
| Jun 2017 | - | -$59.08 M(+7.0%) | -$178.86 M(+22.1%) |
| Mar 2017 | - | -$55.21 M(+63.5%) | -$146.45 M(+23.4%) |
| Dec 2016 | -$118.68 M(+67.9%) | -$33.78 M(+9.7%) | -$118.68 M(+15.2%) |
| Sep 2016 | - | -$30.80 M(+15.5%) | -$103.02 M(+12.3%) |
| Jun 2016 | - | -$26.67 M(-2.8%) | -$91.74 M(+9.9%) |
| Mar 2016 | - | -$27.43 M(+51.4%) | -$83.51 M(+18.2%) |
| Dec 2015 | -$70.68 M(+161.4%) | -$18.12 M(-7.2%) | -$70.68 M(+15.4%) |
| Sep 2015 | - | -$19.52 M(+5.8%) | -$61.23 M(+24.4%) |
| Jun 2015 | - | -$18.44 M(+26.3%) | -$49.20 M(+36.6%) |
| Mar 2015 | - | -$14.61 M(+68.5%) | -$36.03 M(+33.2%) |
| Dec 2014 | -$27.04 M(+54.4%) | -$8.67 M(+15.8%) | -$27.04 M(+15.5%) |
| Sep 2014 | - | -$7.49 M(+42.0%) | -$23.41 M(+11.0%) |
| Jun 2014 | - | -$5.27 M(-6.1%) | -$21.10 M(+5.0%) |
| Mar 2014 | - | -$5.62 M(+11.5%) | -$20.09 M(+14.7%) |
| Dec 2013 | -$17.52 M(+96.2%) | -$5.04 M(-2.6%) | -$17.52 M(+40.4%) |
| Sep 2013 | - | -$5.17 M(+21.2%) | -$12.48 M(+70.8%) |
| Jun 2013 | - | -$4.27 M(+40.3%) | -$7.31 M(+140.3%) |
| Mar 2013 | - | -$3.04 M | -$3.04 M |
| Dec 2012 | -$8.93 M | - | - |
FAQ
- What is Sage Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Sage Therapeutics?
- What is Sage Therapeutics annual CFO year-on-year change?
- What is Sage Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Sage Therapeutics?
- What is Sage Therapeutics quarterly CFO year-on-year change?
- What is Sage Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Sage Therapeutics?
- What is Sage Therapeutics TTM CFO year-on-year change?
What is Sage Therapeutics annual cash flow from operations?
The current annual CFO of SAGE is -$540.59 M
What is the all time high annual CFO for Sage Therapeutics?
Sage Therapeutics all-time high annual cash flow from operations is $664.28 M
What is Sage Therapeutics annual CFO year-on-year change?
Over the past year, SAGE annual cash flow from operations has changed by -$80.55 M (-17.51%)
What is Sage Therapeutics quarterly cash flow from operations?
The current quarterly CFO of SAGE is -$82.36 M
What is the all time high quarterly CFO for Sage Therapeutics?
Sage Therapeutics all-time high quarterly cash flow from operations is $1.01 B
What is Sage Therapeutics quarterly CFO year-on-year change?
Over the past year, SAGE quarterly cash flow from operations has changed by -$1.93 M (-2.40%)
What is Sage Therapeutics TTM cash flow from operations?
The current TTM CFO of SAGE is -$320.15 M
What is the all time high TTM CFO for Sage Therapeutics?
Sage Therapeutics all-time high TTM cash flow from operations is $730.29 M
What is Sage Therapeutics TTM CFO year-on-year change?
Over the past year, SAGE TTM cash flow from operations has changed by +$53.50 M (+14.32%)